ADCT stock results show that ADC Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
Articles
CLDT Stock Earnings: Chatham Lodging Beats EPS, Misses Revenue for Q1 2024
CLDT stock results show that Chatham Lodging beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
PRFT Stock Earnings: Perficient Meets EPS, Misses Revenue for Q1 2024
PRFT stock results show that Perficient met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
Why Is Lyra Therapeutics (LYRA) Stock Down 90% Today?
Lyra Therapeutics stock is falling hard with heavy trading on Monday after the company reported a failed Phase 3 clinical trial. More
Why Is TC Biopharm (TCBP) Stock Up 51% Today?
TC BioPharm stock is rising higher on Monday with heavy trading of TCBP shares after announcing plans to acquire another biotech company. More
Luminar Layoffs 2024: What to Know About the Latest LAZR Job Cuts
Luminar plans to lay off 20% of its workforce, or about 140 people. In the wake of the Luminar layoffs, its shares are sinking. More
BRK/B Stock Earnings: Berkshire Hathaway Inc. New Common Stock Beats EPS, Beats Revenue for Q1 2024
BRK/B stock results show that Berkshire Hathaway Inc. New Common Stock beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
